« Back
Home /
Rivastigmine tartrate

Rivastigmine tartrate

Item no.	TMO-T1628-200mg
Manufacturer	TargetMol
CASRN	129101-54-8
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 50 mg
Category	Neuroscience Molecular Targets for Neuroscience Aging & Neurological Disorders Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,98
Smiles	O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	SDZ-ENA 713,ENA 713
Similar products	129101-54-8
Shipping Condition	Cool pack
Available
Manufacturer - Targets	AChR\|\|\|Cholinesterase (ChE)
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	400.43
Description	Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Pathways	Neuroscience

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T1628-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question